PFE
Pfizer Inc
Pfizer Inc historical holders
total: 18
Gardner Russo & Quinn Pfizer Inc transactions over time
- Total transactions:
- 4
- New positions:
- 2
- Sold out:
- 2
- Held since:
- 2017 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2018 Q1
Thomas Russo has been an institutional investor in Pfizer Inc (PFE) since 2016 Q2. According to 2026 Q1 report, Thomas Russo doesn't hold any shares. The fund/company first acquired PFE in 2016 Q2, initially purchasing 19,900 shares. Thomas Russo later completely sold out the position and reinvested in PFE again in 2017 Q4. Since the initial investment, Gardner Russo & Quinn has made 3 more transactions in this position.
When did Thomas Russo exit their PFE position?
Thomas Russo no longer holds Pfizer Inc (PFE). They sold off their entire position in 2018 Q1, closing out an investment that began in 2016 Q2.
When did Thomas Russo first invest in PFE?
Thomas Russo first invested in Pfizer Inc (PFE) in 2016 Q2 at the reported quarter-end price of $35.23 per share, acquiring 19,900 shares in their initial purchase.
What is Thomas Russo's average cost basis for PFE?
Based on historical transaction data, Thomas Russo's estimated cost basis for Pfizer Inc (PFE) is approximately $36.32 per share. This represents their average reported price* across all buy transactions.
Has Thomas Russo reinvested in PFE after selling?
Yes, Thomas Russo has shown renewed interest in Pfizer Inc (PFE). After completely selling their position, they reinitiated an investment in 2017 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $36.32
- Weighted AVG sell price:
- $36.32
PFE transactions history by Gardner Russo & Quinn
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2018 Q1
|
0.00%
|
$36.32
|
-100% (-1,900)
|
|||
|
2017 Q4
|
0.00%
|
$36.32
|
new
|
|||
|
2016 Q3
|
0.00%
|
$35.23
|
-100% (-19,900)
|
|||
|
2016 Q2
|
0.01%
|
$35.23
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.